Name: Aligos Therapeutics, Inc. (ALGS) Balance Sheet
Creator: FinSpry

Aligos Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Aligos Therapeutics, Inc. (ALGS) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	37.00	135.70	81.35	186.82	243.51
Short-Term Investments	19.94	0.00	44.48	3.92	23.13
Cash & Short-Term Investments	56.94	135.70	125.83	190.73	243.51
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	5.09	5.31	7.60	13.53	5.94
Total Current Assets	62.14	141.08	133.55	204.42	250.02
Non-Current Assets
Property, Plant & Equipment (Net)	7.33	9.82	12.51	14.97	14.91
Long-Term Investments	0.00	0.00	0.00	15.11	0.00
Other Non-Current Assets	0.63	0.63	0.63	0.87	0.38
Total Non-Current Assets	7.95	10.44	13.15	30.95	15.29
Total Assets	70.09	151.53	146.69	235.37	265.30
Current Liabilities
Accounts Payable	2.57	19.36	4.74	3.02	19.88
Short-Term Debt	3.46	0.00	0.00	0.00	0.00
Accrued Liabilities	7.70	16.84	1.47	25.39	16.56
Deferred Revenue	0.15	1.31	9.21	7.64	7.89
Other Current Liabilities	15.56	6.67	0.07	6.33	7.27
Total Current Liabilities	21.74	23.91	33.13	38.96	30.27
Non-Current Liabilities
Long-Term Debt	4.92	7.90	9.43	11.55	10.50
Deferred Tax Liabilities	1.76	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.05	27.64	0.00	0.13	0.38
Total Non-Current Liabilities	77.33	35.50	9.66	11.68	10.88
Total Liabilities	99.07	59.45	42.79	50.64	45.26
Stockholders' Equity
Common Stock	0.01	0.01	0.00	0.00	0.00
Retained Earnings	-618.01	-486.26	-399.12	-303.07	-174.89
Accumulated Other Comprehensive Income	0.45	0.55	0.40	0.45	-0.19
Additional Paid-in Capital	588.58	578.33	502.61	487.35	394.96
Shares Outstanding	3.86	3.00	1.72	1.71	0.00
Total Stockholders' Equity	-28.97	92.08	103.90	184.73	220.08
Total Liabilities & Equity	70.09	151.53	146.69	235.37	265.30